Related Experiment Video
Updated: Apr 27, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice
Maria Damiano1, Clément A Gautier1, Anne-Laure Bulteau2
1Inserm, U 975, CRICM, Hôpital de la Pitié-Salpêtrière, Paris, France; UPMC Université Paris 06, UMR_S975, Paris, France; CNRS, UMR 7225, Paris, France.
Abstract:
Loss of Parkin, encoded by PARK2 gene, is a major cause of autosomal recessive Parkinson's disease. In Drosophila and mammalian cell models Parkin has been shown in to play a role in various processes essential to maintenance of mitochondrial quality, including mitochondrial dynamics, biogenesis and degradation. However, the relevance of altered mitochondrial quality control mechanisms to neuronal survival in vivo is still under debate. We addressed this issue in the brain of PARK2-/- mice using an integrated mitochondrial evaluation, including analysis of respiration by polarography or by fluorescence, respiratory complexes activity by spectrophotometric assays, mitochondrial membrane potential by rhodamine 123 fluorescence, mitochondrial DNA content by real time PCR, and oxidative stress by total glutathione measurement, proteasome activity, SOD2 expression and proteins oxidative damage. Respiration rates were lowered in PARK2-/- brain with high resolution but not standard respirometry. This defect was specific to the striatum, where it was prominent in neurons but less severe in astrocytes. It was present in primary embryonic cells and did not worsen in vivo from 9 to 24 months of age. It was not associated with any respiratory complex defect, including complex I. Mitochondrial inner membrane potential in PARK2-/- mice was similar to that of wild-type mice but showed increased sensitivity to uncoupling with ageing in striatum. The presence of oxidative stress was suggested in the striatum by increased mitochondrial glutathione content and oxidative adducts but normal proteasome activity showed efficient compensation. SOD2 expression was increased only in the striatum of PARK2-/- mice at 24 months of age. Altogether our results show a tissue-specific mitochondrial defect, present early in life of PARK2-/- mice, mildly affecting respiration, without prominent impact on mitochondrial membrane potential, whose underlying mechanisms remain to be elucidated, as complex I defect and prominent oxidative damage were ruled out.
Insights
Parkin deficiency (PARK2) causes Parkinson's disease by impairing mitochondrial function in the brain. This study found mild, early-onset respiratory defects in PARK2 knockout mouse brains, particularly in neurons, without significant oxidative damage.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Genetics
Background:
- Loss of Parkin (encoded by the PARK2 gene) is a primary cause of autosomal recessive Parkinson's disease.
- Parkin plays a role in mitochondrial quality control (dynamics, biogenesis, degradation) in cellular models.
- The in vivo relevance of impaired mitochondrial quality control to neuronal survival in Parkinson's disease remains debated.
Purpose of the Study:
- To investigate the in vivo relevance of altered mitochondrial quality control mechanisms to neuronal survival in PARK2 knockout mice.
- To comprehensively evaluate mitochondrial function in the brain of PARK2-/- mice.
Main Methods:
- Integrated mitochondrial evaluation in PARK2-/- mouse brains.
- Analysis included respiration (polarography/fluorescence), respiratory complex activity, mitochondrial membrane potential (rhodamine 123), mitochondrial DNA content (real-time PCR), and oxidative stress markers (glutathione, proteasome activity, SOD2 expression, protein damage).
Main Results:
- Mildly reduced respiration rates, specific to the striatum and prominent in neurons, were observed in PARK2-/- brains.
- Mitochondrial inner membrane potential was similar to wild-type but showed increased sensitivity to uncoupling with age.
- Evidence of oxidative stress (increased mitochondrial glutathione, oxidative adducts) was detected, but with efficient compensation (normal proteasome activity) and increased SOD2 expression in aged striatum.
Conclusions:
- PARK2 deficiency leads to a tissue-specific, early-onset mitochondrial defect in mouse brain, primarily affecting neuronal respiration.
- The observed defect is mild, not associated with respiratory complex deficiencies (including Complex I), and does not worsen significantly in vivo.
- Underlying mechanisms require further elucidation, as prominent oxidative damage and Complex I defects were ruled out.
More Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Lysosomal Hydrolases
ATP Synthase: Mechanism